No abstract available.
Focal Nodular Hyperplasia*

No abstract available.
Focal Nodular Hyperplasia* ; Humans ; Male*

No abstract available.
Adult ; Female ; Focal Nodular Hyperplasia/*pathology ; Humans

Recent advances in imaging technologies have offered us a great chance to detect a variety of focal liver lesions. Accordingly, it is of paramount importance to determine whether these focal liver lesions are malignant or nonmalignant. Some benign hepatic tumors mimicking hepatocellular carcinoma typically develop from either regenerative or dysplastic/neoplastic processes. The most common benign hepatic solid tumors that are not of vascular origin include focal nodular hyperplasia and hepatocellular adenoma. A majority of patients with benign hepatic tumors are often asymptomatic and require no specific treatment. However, surgical resection may be infrequently needed for cases with clinical symptoms or malignant potential. This review will touch on the epidemiology, pathogenesis, clinical features, diagnosis, and management of focal nodular hyperplasia and hepatocellular adenoma.
Adenoma, Liver Cell ; Carcinoma, Hepatocellular ; Focal Nodular Hyperplasia ; Humans ; Liver

Thyroid carcinogenesis is traditionally thought to originate 'de novo'. However, it is debatable whether a malignant transformation can possibly arise from a benign thyroid nodule, as suggested for the malignant transformation of a thyroid adenoma. To the best of our knowledge, no studies have been performed addressing the malignant transformation of nodular hyperplasia in the thyroid gland. Here, we report a case of nodular hyperplasia with focally malignant degeneration.
Carcinogenesis ; Cell Transformation, Neoplastic ; Focal Nodular Hyperplasia ; Hyperplasia* ; Thyroid Gland* ; Thyroid Neoplasms ; Thyroid Nodule

Telangiectatic focal nodular hyperplasia (FNH) denotes atypical lesions considered as variants of FNH. FNH of the liver is characterized by stellate central scars with dysplastic vessels and hyperplastic nodules. It is the second most common benign hepatic tumor following hemangioma. However, telangiectatic FNH is extremely rare in the perinatal period and only three cases were reported in the literature. We recently experienced a case of telangiectatic FNH in a newborn. This lesion was detected on the prenatal ultrasonographic examination performed at the 36th weeks of gestation, and confirmed by the right lobectomy after birth. We report this case with a brief review of the literature.
Cicatrix ; Focal Nodular Hyperplasia* ; Hemangioma ; Humans ; Infant, Newborn* ; Liver* ; Parturition ; Pregnancy ; Telangiectasis

Focal nodular hyperplvasia (FNH) is a rare benign hepatic tumor that likely represents a local hyperplastic response of hepatocytes to a congenital vascular anomaly. FNH is typically asymtomatic and has a benign course. Hepatic resection is performed when the lesions are large, symptomatic and complicated or when the diagnosis remains uncertain. Although many cases of FNH in children have been described to date in other countries, only one Korean case of multiple FNH has been reported on English literature. We recently experienced a rare case of multiple FNH in a 10-year-old boy, that was confirmed by right inferior subsegmentectomy, left lateral segmentectomy and left medial tumorectomy. We report this case with brief review of literature.
Child ; Diagnosis ; Focal Nodular Hyperplasia* ; Hepatocytes ; Humans ; Liver* ; Male ; Mastectomy, Segmental

Focal nodular hyperplasia (FNH) is a benig nepithelial tumor of the liver. The etiology of FNH is unknown, but recent evidence suggests that FNH may represent a localized, hyperplastic response to a pre-existing vascular malformat ion. There is a high probability of as sociat edlesions , most commonly hepatic hemangiomas, meningioma, as trocytoma, and arterial dysplasia in various organs . In the present report we describe a FNH with aberrant lymphatics in a 24-year-old woman. In operation field, lymphatics were located on the site of falciform ligament. Histologically, aberrant lymphatics were composed of well vas cularized complex lymphatic channels and the mass were typical FNH. In this case, the role of aberrant lymphatics in the development of FNH was unclear . But as the FNH frequently as sociated with ot her anomalies , we think the aberrant lymphatic as such anomaly that have not been reported.
Carcinoma, Hepatocellular* ; Female ; Focal Nodular Hyperplasia ; Hemangioma ; Humans ; Ligaments ; Liver ; Meningioma ; Young Adult

Focal nodular hyperplasia (FNH) is a rare benign hepatic tumor occurring predominantly in women of childbearing age. Generally oral contraceptive is not associated with FNH but might accentuate the vascular abnormalities which may cause the lesion to enlarge and, very rarely, to rupture. FNH is typically asymptomatic and seldom bleeds. Often it is incidentally observed during imaging procedures performed for some other reasons. The histologic feature of FNH is characterized by areas of localized growth of mature hepatocytes and septal fibrosis. Surgical resection is seldom required because of the benign nature of the lesion and its lack of significant complication. We experienced a case of focal nodular hyperplasia without liver cirrhosis confirmed by surgical resection and histologic examination. in a 47-year-old man.
Female ; Fibrosis ; Focal Nodular Hyperplasia* ; Hepatocytes ; Humans ; Liver Cirrhosis ; Liver* ; Middle Aged ; Rupture

PURPOSE: To analyze the morphologic and enhancement patterns of focal nodular hyperplasia (FNH) of the liver observed at triphasic helical CT. MATERIALS AND METHODS: The triphasic helical CT findings of 15 pathologically-proven FNHs in 15 patients (male: female = 7:8; mean age, 40 years) were retrospectively analyzed. Triphasic helical CT images were obtained at 30 secs (arterial phase), 70 secs (portal phase), and 3 mins (equilibrium phase) after the initiation of contrast injection of a total of 120 mL nonionic contrast material at a rate of 3 mL/sec. Image analysis focused on the morphologic and enhancement patterns of the FNHs. Morphologically, their size and margin conspicuity were determined, as well as the presence or absence of a capsule, central scar, malformed arterial vessel, calcification, and mosaic pattern. As for the enhancement pattern, the degree of tumor enhancement (hyper-, iso-, or hypoattenuation) was compared with the surrounding hepatic parenchyma at each phase. All hyperattenuating FNHs were further analyzed after dividing them into two groups, strongly and weakly enhanced. RESULTS: Ten of the 15 tumors were less than 3 cm in diameter. With regard to the other morphologic parameters, a central scar, malformed arterial vessel, and capsule were found in four, four, and five FNHs, respectively. Eleven FNHs showed hyperattenuation, with strong enhancement at the arterial phase. During the portal and equilibrium phases, the enhancement pattern changed to iso- or hypoattenuation in nine and 13 FNHs, respectively. Of six hyperattenuating FNHs at the portal phase, five were weakly enhanced. CONCLUSION: Though our sample was small, we found that FNHs were hyperattenuating lesions, strongly enhanced at the arterial phase but iso- or hypoattenuating during the portal and equilibrium phases. A central scar, malformed arterial vessel, and capsule were observed fairly frequently. Thus, for the differentiation of FNH from other hypervascular hepatic tumors, precise recognition of their CT findings is important.
Cicatrix ; Female ; Focal Nodular Hyperplasia* ; Humans ; Liver* ; Retrospective Studies ; Tomography, Spiral Computed*